At Premium Cannabis, we are committed to supporting practitioner-led medicinal cannabis education while operating within Australian healthcare and regulatory frameworks. This page outlines important legal, privacy, and compliance considerations relevant to website users, healthcare professionals, and patients seeking general educational information regarding medicinal cannabis pathways in Australia.
Medicinal cannabis products in Australia are regulated under national healthcare legislation and therapeutic goods frameworks overseen by the Therapeutic Goods Administration (TGA) and other relevant regulatory bodies.
• medicinal cannabis products are prescription-only medicines
• practitioner assessment is required before access pathways may be considered
• products must be dispensed through licensed pharmacy systems
• healthcare practitioners operate within Australian prescribing and compliance frameworks
• access pathways may involve Special Access Scheme (SAS) or Authorised Prescriber systems where appropriate
Premium Cannabis does not provide medicinal cannabis products directly to consumers without practitioner involvement or regulated dispensing processes.
Patients seeking broader educational resources may also review Accessing Medical Cannabis and Healthcare Consultation Pathways.
Premium Cannabis recognises the importance of protecting personal and healthcare information in accordance with Australian privacy legislation, including the Privacy Act 1988.
Healthcare communication systems may involve collection of information such as:
• contact information
• consultation requests
• practitioner communication records
• prescription coordination details
• healthcare support enquiries
Australian healthcare environments continue prioritising:
• patient confidentiality
• secure information handling
• regulated communication systems
• privacy compliance standards
Information may be shared with licensed healthcare providers, pharmacies, or regulatory authorities where required under Australian law or healthcare coordination processes.
This website provides general educational information only and does not constitute medical advice, diagnosis, or treatment recommendations.
Content published on this website is intended to support understanding of:
• practitioner-led medicinal cannabis pathways
• healthcare accessibility systems
• consultation processes
• regulatory frameworks
• pharmacy coordination pathways
Users should always seek guidance from qualified healthcare practitioners regarding individual healthcare circumstances.
Premium Cannabis does not:
• advertise prescription medicines directly to the public
• guarantee prescriptions or healthcare outcomes
• encourage self-diagnosis or self-medication
• provide therapeutic guarantees regarding medicinal cannabis products
Patients exploring broader healthcare education may also review Patient Information and Support and Scientific Research and Development.
By accessing this website, users acknowledge and accept that:
• all information is educational in nature
• healthcare decisions should occur with practitioner oversight
• Australian healthcare and regulatory laws apply
• website content may be updated periodically
• intellectual property remains protected under applicable laws
Premium Cannabis reserves the right to update website information, healthcare communication materials, and educational resources where required to maintain regulatory alignment and operational accuracy.
Medicinal cannabis products in Australia are available only via prescription and within regulated healthcare frameworks.
This website does not:
• replace consultation with a qualified healthcare practitioner
• advertise prescription medicines
• provide unverified therapeutic claims
• guarantee healthcare outcomes or product suitability
This website provides general educational information only and does not constitute medical advice.